FdaApplication

NDA 215092

Back to search

Identifiers

Properties

PropertyValue
applicant_nameOCUVEX THERAPEUTICS INC
application_typeNDA
approval_date2022-09-22

Products (1)

ProductActive ingredientStrengthDosage form
OMLONTIOMIDENEPAG ISOPROPYL0.002%SOLUTION;OPHTHALMIC

1 product